Mehul Joshi
CIK 1939602 · Chief Financial Officer & PAO · last filed 2025-09-03
Mehul Joshi is a Chief Financial Officer & PAO who has filed 9 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing shows the insider sold $12.7K of LUNG on Sep 3, 2025. Across all open-market trades the lifetime net is −$140.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $290.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$290.7K
3
9
-$140.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LUNG | Chief Financial Officer & PAO | 212,154 | $1.37 | $290.7K | -$140.3K | 4 | 2025-09-03 |
| Bruker Cellular Analysis, Inc. (CELL) Delisted | Chief Financial Officer | 65,013 | $1.00 | $64.9K | $0 | 3 | 2023-10-03 |
| Bruker Cellular Analysis, Inc. (BLI) Delisted | Chief Financial Officer | 516,942 | $1.20 | $620.3K | $0 | 2 | 2023-03-07 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-03 | LUNG | Sell (S) | −7,936 | -$12.7K | EDGAR |
| 2025-06-04 | LUNG | Sell (S) | −8,061 | -$25.2K | EDGAR |
| 2025-03-05 | LUNG | Mixed | +93,616 | -$102.4K | EDGAR |
| 2024-05-07 | LUNG | Grant (A) | +125,870 | $0 | EDGAR |
| 2023-10-03 | Bruker Cellular Analysis, Inc. (CELL) Delisted | Mixed | −840,530 | $0 | EDGAR |
| 2023-07-28 | Bruker Cellular Analysis, Inc. (CELL) Delisted | Tax (F) | −26,412 | -$14.5K | EDGAR |
| 2023-06-01 | Bruker Cellular Analysis, Inc. (CELL) Delisted | Grant (A) | +350,000 | $0 | EDGAR |
| 2023-03-07 | Bruker Cellular Analysis, Inc. (BLI) Delisted | Mixed | +227,586 | -$24.4K | EDGAR |
| 2022-07-26 | Bruker Cellular Analysis, Inc. (BLI) Delisted | Grant (A) | +287,356 | $0 | EDGAR |